APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Radioactive Nucleic Acid Labeling

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non-Radioactive Nucleic Acid Labeling Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025195 pages

Choose your research edition.

Industry ResearchNon-Radioactive Nucleic Acid Labeling Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Radioactive Nucleic Acid Labeling Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Non-Radioactive Nucleic Acid Labeling Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Radioactive Nucleic Acid Labeling Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Radioactive Nucleic Acid Labeling Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Non-Radioactive Nucleic Acid Labeling market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Non-Radioactive Nucleic Acid Labeling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-Radioactive Nucleic Acid Labeling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Radioactive Nucleic Acid Labeling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non-Radioactive Nucleic Acid Labeling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-Radioactive Nucleic Acid Labeling include Thermo Fisher Scientific, Merck KGaA, Roche, Vector Labs, Promega, PerkinElmer, New England Biolabs, General Electric and Enzo Biochem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-Radioactive Nucleic Acid Labeling market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-Radioactive Nucleic Acid Labeling and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-Radioactive Nucleic Acid Labeling sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-Radioactive Nucleic Acid Labeling market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-Radioactive Nucleic Acid Labeling Segment by Company

Thermo Fisher Scientific

Merck KGaA

Roche

Vector Labs

Promega

PerkinElmer

New England Biolabs

General Electric

Enzo Biochem

Agilent Technologies

Non-Radioactive Nucleic Acid Labeling Segment by Type

DIG System

Biotin

Fluorescent

Others

Non-Radioactive Nucleic Acid Labeling Segment by Application

DNA Labeling

RNA Labeling

Oligonucleotide Labeling

Non-Radioactive Nucleic Acid Labeling Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Radioactive Nucleic Acid Labeling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Radioactive Nucleic Acid Labeling and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Radioactive Nucleic Acid Labeling.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-Radioactive Nucleic Acid Labeling market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-Radioactive Nucleic Acid Labeling manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non-Radioactive Nucleic Acid Labeling in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Non-Radioactive Nucleic Acid Labeling in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Non-Radioactive Nucleic Acid Labeling Industry Trends Table 2. Non-Radioactive Nucleic Acid Labeling Industry Drivers Table 3. Non-Radioactive Nucleic Acid Labeling Industry Opportunities and Challenges Table 4. Non-Radioactive Nucleic Acid Labeling Industry Restraints Table 5. Global Non-Radioactive Nucleic Acid Labeling Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Non-Radioactive Nucleic Acid Labeling Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Non-Radioactive Nucleic Acid Labeling Sales Market Share by Manufacturers Table 9. Global Non-Radioactive Nucleic Acid Labeling Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Non-Radioactive Nucleic Acid Labeling Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Non-Radioactive Nucleic Acid Labeling Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Non-Radioactive Nucleic Acid Labeling Manufacturers, Product Type & Application Table 13. Global Non-Radioactive Nucleic Acid Labeling Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-Radioactive Nucleic Acid Labeling by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of DIG System Table 17. Major Manufacturers of Biotin Table 18. Major Manufacturers of Fluorescent Table 19. Major Manufacturers of Others Table 20. Global Non-Radioactive Nucleic Acid Labeling Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Non-Radioactive Nucleic Acid Labeling Sales by Type (2021-2026) & (K Units) Table 22. Global Non-Radioactive Nucleic Acid Labeling Sales by Type (2027-2032) & (K Units) Table 23. Global Non-Radioactive Nucleic Acid Labeling Sales Market Share by Type (2021-2026) Table 24. Global Non-Radioactive Nucleic Acid Labeling Sales Market Share by Type (2027-2032) Table 25. Global Non-Radioactive Nucleic Acid Labeling Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Non-Radioactive Nucleic Acid Labeling Revenue by Type (2021-2026) & (K Units) Table 27. Global Non-Radioactive Nucleic Acid Labeling Revenue by Type (2027-2032) & (K Units) Table 28. Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Type (2021-2026) Table 29. Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of DNA Labeling Table 31. Major Manufacturers of RNA Labeling Table 32. Major Manufacturers of Oligonucleotide Labeling Table 33. Global Non-Radioactive Nucleic Acid Labeling Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Non-Radioactive Nucleic Acid Labeling Sales by Application (2021-2026) & (K Units) Table 35. Global Non-Radioactive Nucleic Acid Labeling Sales by Application (2027-2032) & (K Units) Table 36. Global Non-Radioactive Nucleic Acid Labeling Sales Market Share by Application (2021-2026) Table 37. Global Non-Radioactive Nucleic Acid Labeling Sales Market Share by Application (2027-2032) Table 38. Global Non-Radioactive Nucleic Acid Labeling Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Non-Radioactive Nucleic Acid Labeling Revenue by Application (2021-2026) & (K Units) Table 40. Global Non-Radioactive Nucleic Acid Labeling Revenue by Application (2027-2032) & (K Units) Table 41. Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Application (2021-2026) Table 42. Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Application (2027-2032) Table 43. Global Non-Radioactive Nucleic Acid Labeling Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Non-Radioactive Nucleic Acid Labeling Sales by Region (2021-2026) & (K Units) Table 45. Global Non-Radioactive Nucleic Acid Labeling Sales Market Share by Region (2021-2026) Table 46. Global Non-Radioactive Nucleic Acid Labeling Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Non-Radioactive Nucleic Acid Labeling Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Non-Radioactive Nucleic Acid Labeling Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Non-Radioactive Nucleic Acid Labeling Sales by Country (2021-2026) & (K Units) Table 50. North America Non-Radioactive Nucleic Acid Labeling Sales by Country (2027-2032) & (K Units) Table 51. Europe Non-Radioactive Nucleic Acid Labeling Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Non-Radioactive Nucleic Acid Labeling Sales by Country (2021-2026) & (K Units) Table 53. Europe Non-Radioactive Nucleic Acid Labeling Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Non-Radioactive Nucleic Acid Labeling Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Non-Radioactive Nucleic Acid Labeling Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Non-Radioactive Nucleic Acid Labeling Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Non-Radioactive Nucleic Acid Labeling Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Non-Radioactive Nucleic Acid Labeling Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Non-Radioactive Nucleic Acid Labeling Sales by Country (2027-2032) & (K Units) Table 60. Global Non-Radioactive Nucleic Acid Labeling Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Non-Radioactive Nucleic Acid Labeling Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Non-Radioactive Nucleic Acid Labeling Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Region (2021-2026) Table 64. Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Region (2027-2032) Table 65. Thermo Fisher Scientific Company Information Table 66. Thermo Fisher Scientific Business Overview Table 67. Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Product Portfolio Table 69. Thermo Fisher Scientific Recent Development Table 70. Merck KGaA Company Information Table 71. Merck KGaA Business Overview Table 72. Merck KGaA Non-Radioactive Nucleic Acid Labeling Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Merck KGaA Non-Radioactive Nucleic Acid Labeling Product Portfolio Table 74. Merck KGaA Recent Development Table 75. Roche Company Information Table 76. Roche Business Overview Table 77. Roche Non-Radioactive Nucleic Acid Labeling Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Roche Non-Radioactive Nucleic Acid Labeling Product Portfolio Table 79. Roche Recent Development Table 80. Vector Labs Company Information Table 81. Vector Labs Business Overview Table 82. Vector Labs Non-Radioactive Nucleic Acid Labeling Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Vector Labs Non-Radioactive Nucleic Acid Labeling Product Portfolio Table 84. Vector Labs Recent Development Table 85. Promega Company Information Table 86. Promega Business Overview Table 87. Promega Non-Radioactive Nucleic Acid Labeling Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Promega Non-Radioactive Nucleic Acid Labeling Product Portfolio Table 89. Promega Recent Development Table 90. PerkinElmer Company Information Table 91. PerkinElmer Business Overview Table 92. PerkinElmer Non-Radioactive Nucleic Acid Labeling Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. PerkinElmer Non-Radioactive Nucleic Acid Labeling Product Portfolio Table 94. PerkinElmer Recent Development Table 95. New England Biolabs Company Information Table 96. New England Biolabs Business Overview Table 97. New England Biolabs Non-Radioactive Nucleic Acid Labeling Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. New England Biolabs Non-Radioactive Nucleic Acid Labeling Product Portfolio Table 99. New England Biolabs Recent Development Table 100. General Electric Company Information Table 101. General Electric Business Overview Table 102. General Electric Non-Radioactive Nucleic Acid Labeling Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. General Electric Non-Radioactive Nucleic Acid Labeling Product Portfolio Table 104. General Electric Recent Development Table 105. Enzo Biochem Company Information Table 106. Enzo Biochem Business Overview Table 107. Enzo Biochem Non-Radioactive Nucleic Acid Labeling Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Enzo Biochem Non-Radioactive Nucleic Acid Labeling Product Portfolio Table 109. Enzo Biochem Recent Development Table 110. Agilent Technologies Company Information Table 111. Agilent Technologies Business Overview Table 112. Agilent Technologies Non-Radioactive Nucleic Acid Labeling Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Agilent Technologies Non-Radioactive Nucleic Acid Labeling Product Portfolio Table 114. Agilent Technologies Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Non-Radioactive Nucleic Acid Labeling Distributors List Table 118. Non-Radioactive Nucleic Acid Labeling Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Non-Radioactive Nucleic Acid Labeling Product Image Figure 2. Global Non-Radioactive Nucleic Acid Labeling Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Radioactive Nucleic Acid Labeling Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-Radioactive Nucleic Acid Labeling Sales (2021-2032) & (K Units) Figure 5. Global Non-Radioactive Nucleic Acid Labeling Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Non-Radioactive Nucleic Acid Labeling Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. DIG System Image Figure 9. Biotin Image Figure 10. Fluorescent Image Figure 11. Others Image Figure 12. Global Non-Radioactive Nucleic Acid Labeling Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Non-Radioactive Nucleic Acid Labeling Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Non-Radioactive Nucleic Acid Labeling Sales Market Share by Type (2021-2032) Figure 15. Global Non-Radioactive Nucleic Acid Labeling Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Type (2021-2032) Figure 18. DNA Labeling Image Figure 19. RNA Labeling Image Figure 20. Oligonucleotide Labeling Image Figure 21. Global Non-Radioactive Nucleic Acid Labeling Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Non-Radioactive Nucleic Acid Labeling Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Non-Radioactive Nucleic Acid Labeling Sales Market Share by Application (2021-2032) Figure 24. Global Non-Radioactive Nucleic Acid Labeling Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Application (2021-2032) Figure 27. North America Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Non-Radioactive Nucleic Acid Labeling Sales Market Share by Country (2021-2032) Figure 29. U.S. Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Non-Radioactive Nucleic Acid Labeling Sales Market Share by Country (2021-2032) Figure 34. Germany Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Non-Radioactive Nucleic Acid Labeling Sales Market Share by Country (2021-2032) Figure 41. China Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Non-Radioactive Nucleic Acid Labeling Sales Market Share by Country (2021-2032) Figure 49. Brazil Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Non-Radioactive Nucleic Acid Labeling Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Non-Radioactive Nucleic Acid Labeling Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Non-Radioactive Nucleic Acid Labeling Revenue (2021-2032) & (US$ Million) Figure 60. North America Non-Radioactive Nucleic Acid Labeling Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Non-Radioactive Nucleic Acid Labeling Revenue (2021-2032) & (US$ Million) Figure 62. Europe Non-Radioactive Nucleic Acid Labeling Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Non-Radioactive Nucleic Acid Labeling Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Non-Radioactive Nucleic Acid Labeling Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Non-Radioactive Nucleic Acid Labeling Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Non-Radioactive Nucleic Acid Labeling Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Non-Radioactive Nucleic Acid Labeling Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Non-Radioactive Nucleic Acid Labeling Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • DIG System
  • Biotin
  • Fluorescent
  • Others
Applications
  • DNA Labeling
  • RNA Labeling
  • Oligonucleotide Labeling
Companies covered
  • Thermo Fisher Scientific
  • Merck KGaA
  • Roche
  • Vector Labs
  • Promega
  • PerkinElmer
  • New England Biolabs
  • General Electric
  • Enzo Biochem
  • Agilent Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-Radioactive Nucleic Acid Labeling Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-Radioactive Nucleic Acid Labeling Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Non-Radioactive Nucleic Acid Labeling Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Non-Radioactive Nucleic Acid Labeling Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Non-Radioactive Nucleic Acid Labeling Market Dynamics
  1. 2.1 Non-Radioactive Nucleic Acid Labeling Industry Trends
  2. 2.2 Non-Radioactive Nucleic Acid Labeling Industry Drivers
  3. 2.3 Non-Radioactive Nucleic Acid Labeling Industry Opportunities and Challenges
  4. 2.4 Non-Radioactive Nucleic Acid Labeling Industry Restraints
3 Non-Radioactive Nucleic Acid Labeling Market by Manufacturers
  1. 3.1 Global Non-Radioactive Nucleic Acid Labeling Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Non-Radioactive Nucleic Acid Labeling Sales by Manufacturers (2021-2026)
  3. 3.3 Global Non-Radioactive Nucleic Acid Labeling Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Non-Radioactive Nucleic Acid Labeling Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-Radioactive Nucleic Acid Labeling Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Non-Radioactive Nucleic Acid Labeling Manufacturers, Product Type & Application
  7. 3.7 Global Non-Radioactive Nucleic Acid Labeling Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-Radioactive Nucleic Acid Labeling Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-Radioactive Nucleic Acid Labeling Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-Radioactive Nucleic Acid Labeling Tier 1, Tier 2, and Tier 3
4 Non-Radioactive Nucleic Acid Labeling Market by Type
  1. 4.1 Non-Radioactive Nucleic Acid Labeling Type Introduction
  2. 4.1.1 DIG System
  3. 4.1.2 Biotin
  4. 4.1.3 Fluorescent
  5. 4.1.4 Others
  6. 4.2 Global Non-Radioactive Nucleic Acid Labeling Sales by Type
  7. 4.2.1 Global Non-Radioactive Nucleic Acid Labeling Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Non-Radioactive Nucleic Acid Labeling Sales by Type (2021-2032)
  9. 4.2.3 Global Non-Radioactive Nucleic Acid Labeling Sales Market Share by Type (2021-2032)
  10. 4.3 Global Non-Radioactive Nucleic Acid Labeling Revenue by Type
  11. 4.3.1 Global Non-Radioactive Nucleic Acid Labeling Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Non-Radioactive Nucleic Acid Labeling Revenue by Type (2021-2032)
  13. 4.3.3 Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Type (2021-2032)
5 Non-Radioactive Nucleic Acid Labeling Market by Application
  1. 5.1 Non-Radioactive Nucleic Acid Labeling Application Introduction
  2. 5.1.1 DNA Labeling
  3. 5.1.2 RNA Labeling
  4. 5.1.3 Oligonucleotide Labeling
  5. 5.2 Global Non-Radioactive Nucleic Acid Labeling Sales by Application
  6. 5.2.1 Global Non-Radioactive Nucleic Acid Labeling Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-Radioactive Nucleic Acid Labeling Sales by Application (2021-2032)
  8. 5.2.3 Global Non-Radioactive Nucleic Acid Labeling Sales Market Share by Application (2021-2032)
  9. 5.3 Global Non-Radioactive Nucleic Acid Labeling Revenue by Application
  10. 5.3.1 Global Non-Radioactive Nucleic Acid Labeling Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Non-Radioactive Nucleic Acid Labeling Revenue by Application (2021-2032)
  12. 5.3.3 Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Application (2021-2032)
6 Global Non-Radioactive Nucleic Acid Labeling Sales by Region
  1. 6.1 Global Non-Radioactive Nucleic Acid Labeling Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-Radioactive Nucleic Acid Labeling Sales by Region (2021-2032)
  3. 6.2.1 Global Non-Radioactive Nucleic Acid Labeling Sales by Region (2021-2026)
  4. 6.2.2 Global Non-Radioactive Nucleic Acid Labeling Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-Radioactive Nucleic Acid Labeling Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Non-Radioactive Nucleic Acid Labeling Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Non-Radioactive Nucleic Acid Labeling Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Non-Radioactive Nucleic Acid Labeling Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Non-Radioactive Nucleic Acid Labeling Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Non-Radioactive Nucleic Acid Labeling Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Non-Radioactive Nucleic Acid Labeling Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Non-Radioactive Nucleic Acid Labeling Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Non-Radioactive Nucleic Acid Labeling Revenue by Region
  1. 7.1 Global Non-Radioactive Nucleic Acid Labeling Revenue by Region
  2. 7.1.1 Global Non-Radioactive Nucleic Acid Labeling Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Non-Radioactive Nucleic Acid Labeling Revenue by Region (2021-2026)
  4. 7.1.3 Global Non-Radioactive Nucleic Acid Labeling Revenue by Region (2027-2032)
  5. 7.1.4 Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Non-Radioactive Nucleic Acid Labeling Revenue (2021-2032)
  8. 7.2.2 North America Non-Radioactive Nucleic Acid Labeling Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Non-Radioactive Nucleic Acid Labeling Revenue (2021-2032)
  11. 7.3.2 Europe Non-Radioactive Nucleic Acid Labeling Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Non-Radioactive Nucleic Acid Labeling Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Non-Radioactive Nucleic Acid Labeling Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Non-Radioactive Nucleic Acid Labeling Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Non-Radioactive Nucleic Acid Labeling Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Merck KGaA
  8. 8.2.1 Merck KGaA Company Information
  9. 8.2.2 Merck KGaA Business Overview
  10. 8.2.3 Merck KGaA Non-Radioactive Nucleic Acid Labeling Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck KGaA Non-Radioactive Nucleic Acid Labeling Product Portfolio
  12. 8.2.5 Merck KGaA Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Non-Radioactive Nucleic Acid Labeling Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Non-Radioactive Nucleic Acid Labeling Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Vector Labs
  20. 8.4.1 Vector Labs Company Information
  21. 8.4.2 Vector Labs Business Overview
  22. 8.4.3 Vector Labs Non-Radioactive Nucleic Acid Labeling Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Vector Labs Non-Radioactive Nucleic Acid Labeling Product Portfolio
  24. 8.4.5 Vector Labs Recent Developments
  25. 8.5 Promega
  26. 8.5.1 Promega Company Information
  27. 8.5.2 Promega Business Overview
  28. 8.5.3 Promega Non-Radioactive Nucleic Acid Labeling Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Promega Non-Radioactive Nucleic Acid Labeling Product Portfolio
  30. 8.5.5 Promega Recent Developments
  31. 8.6 PerkinElmer
  32. 8.6.1 PerkinElmer Company Information
  33. 8.6.2 PerkinElmer Business Overview
  34. 8.6.3 PerkinElmer Non-Radioactive Nucleic Acid Labeling Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PerkinElmer Non-Radioactive Nucleic Acid Labeling Product Portfolio
  36. 8.6.5 PerkinElmer Recent Developments
  37. 8.7 New England Biolabs
  38. 8.7.1 New England Biolabs Company Information
  39. 8.7.2 New England Biolabs Business Overview
  40. 8.7.3 New England Biolabs Non-Radioactive Nucleic Acid Labeling Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 New England Biolabs Non-Radioactive Nucleic Acid Labeling Product Portfolio
  42. 8.7.5 New England Biolabs Recent Developments
  43. 8.8 General Electric
  44. 8.8.1 General Electric Company Information
  45. 8.8.2 General Electric Business Overview
  46. 8.8.3 General Electric Non-Radioactive Nucleic Acid Labeling Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 General Electric Non-Radioactive Nucleic Acid Labeling Product Portfolio
  48. 8.8.5 General Electric Recent Developments
  49. 8.9 Enzo Biochem
  50. 8.9.1 Enzo Biochem Company Information
  51. 8.9.2 Enzo Biochem Business Overview
  52. 8.9.3 Enzo Biochem Non-Radioactive Nucleic Acid Labeling Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Enzo Biochem Non-Radioactive Nucleic Acid Labeling Product Portfolio
  54. 8.9.5 Enzo Biochem Recent Developments
  55. 8.10 Agilent Technologies
  56. 8.10.1 Agilent Technologies Company Information
  57. 8.10.2 Agilent Technologies Business Overview
  58. 8.10.3 Agilent Technologies Non-Radioactive Nucleic Acid Labeling Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Agilent Technologies Non-Radioactive Nucleic Acid Labeling Product Portfolio
  60. 8.10.5 Agilent Technologies Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-Radioactive Nucleic Acid Labeling Value Chain Analysis
  2. 9.1.1 Non-Radioactive Nucleic Acid Labeling Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-Radioactive Nucleic Acid Labeling Production Mode & Process
  6. 9.2 Non-Radioactive Nucleic Acid Labeling Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-Radioactive Nucleic Acid Labeling Distributors
  9. 9.2.3 Non-Radioactive Nucleic Acid Labeling Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst